DK2726883T4 - Cellemedieret immunresponsanalyse med forbedret følsomhed - Google Patents

Cellemedieret immunresponsanalyse med forbedret følsomhed Download PDF

Info

Publication number
DK2726883T4
DK2726883T4 DK12804281.9T DK12804281T DK2726883T4 DK 2726883 T4 DK2726883 T4 DK 2726883T4 DK 12804281 T DK12804281 T DK 12804281T DK 2726883 T4 DK2726883 T4 DK 2726883T4
Authority
DK
Denmark
Prior art keywords
cell
immune response
mediated immune
improved sensitivity
response assay
Prior art date
Application number
DK12804281.9T
Other languages
English (en)
Other versions
DK2726883T3 (da
Inventor
Jeff Boyle
Original Assignee
Cellestis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47423289&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2726883(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cellestis Ltd filed Critical Cellestis Ltd
Application granted granted Critical
Publication of DK2726883T3 publication Critical patent/DK2726883T3/da
Publication of DK2726883T4 publication Critical patent/DK2726883T4/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK12804281.9T 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed DK2726883T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502811P 2011-06-29 2011-06-29
PCT/AU2012/000756 WO2013000021A1 (en) 2011-06-29 2012-06-27 A cell mediated immune response assay with enhanced sensitivity

Publications (2)

Publication Number Publication Date
DK2726883T3 DK2726883T3 (da) 2018-07-16
DK2726883T4 true DK2726883T4 (da) 2022-08-22

Family

ID=47423289

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12804281.9T DK2726883T4 (da) 2011-06-29 2012-06-27 Cellemedieret immunresponsanalyse med forbedret følsomhed

Country Status (20)

Country Link
US (2) US9983207B2 (da)
EP (2) EP3351936A1 (da)
JP (1) JP6150177B2 (da)
KR (1) KR102022513B1 (da)
CN (3) CN108593936B (da)
AU (4) AU2012276280B2 (da)
BR (1) BR112013033520B1 (da)
CA (1) CA2840484C (da)
CY (1) CY1120633T1 (da)
DK (1) DK2726883T4 (da)
ES (1) ES2673697T5 (da)
HU (1) HUE037801T2 (da)
LT (1) LT2726883T (da)
MX (1) MX357717B (da)
PT (1) PT2726883T (da)
RU (2) RU2018107763A (da)
SI (1) SI2726883T2 (da)
TR (1) TR201808740T4 (da)
WO (1) WO2013000021A1 (da)
ZA (1) ZA201309155B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2367561B1 (en) 2008-11-30 2015-05-20 Immusant, Inc. Compositions and methods for treatment of celiac disease
JP2012167952A (ja) * 2011-02-10 2012-09-06 Central Automotive Products Ltd アルコール検知器
SI2726883T2 (sl) 2011-06-29 2022-09-30 Cellestis Limited Test celično posredovanega imunskega odziva s povečano občutljivostjo
JP6123282B2 (ja) * 2012-12-20 2017-05-10 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
HUE038527T2 (hu) * 2012-12-28 2018-10-29 Cellestis Ltd Sejtek által közvetített immunválasz
JP2014229116A (ja) * 2013-05-23 2014-12-08 富士電機株式会社 プログラマブルコントローラおよび電源切断対処方法
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
AU2015323979A1 (en) 2014-09-29 2017-05-18 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease
EP3210015A1 (en) * 2014-10-23 2017-08-30 Qiagen Sciences, LLC Peptide composition and uses thereof
EP3302457A2 (en) 2015-06-08 2018-04-11 Lophius Biosciences GmbH Composition for determination of cell-mediated immune responsiveness
GB201605210D0 (en) * 2016-03-29 2016-05-11 Oxford Immunotec Ltd Assay
AU2019253924A1 (en) * 2018-04-19 2020-11-26 StickyCell Pty Ltd Leukocyte recruitment in infectious disease
EP3775894B1 (en) * 2018-05-11 2024-04-24 OBI Pharma, Inc. Method for predicting human immune response
JP6796737B1 (ja) * 2020-06-02 2020-12-09 振武 曽 多項目自動血球計数装置
EP4179328A2 (en) * 2020-07-10 2023-05-17 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
CN114062665B (zh) * 2020-08-05 2023-04-28 菲鹏生物股份有限公司 示踪粒子标记目标分子及其制备方法和应用
CN113238060B (zh) * 2021-05-08 2022-10-11 迈克生物股份有限公司 用于预测或诊断心肌炎的试剂盒

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US20020131976A1 (en) 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
DE60130435T2 (de) * 2000-02-24 2009-07-23 Invitrogen Corp., Carlsbad Gleichzeitige stimulation und konzentration von zellen
AUPQ689900A0 (en) 2000-04-14 2000-05-11 Commonwealth Scientific And Industrial Research Organisation Bubble acoustics
DK1432439T3 (da) * 2001-10-02 2006-04-03 Mologen Ag Middel til forbedring af immunsvaret
WO2004004758A1 (en) * 2002-07-05 2004-01-15 Lipoxen Technologies Limited Method to enhance an immune response of nucleic acid vaccination
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
EP1751181B1 (en) 2004-06-02 2012-08-15 AdAlta Pty Ltd BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
AU2008229636B2 (en) * 2007-03-16 2014-08-14 QIAGEN Australia Holding Pty. Ltd. A cell-mediated immune response assay and kits therefor
BRPI0817052A2 (pt) * 2007-08-30 2015-03-24 Genentech Inc Métodos para o tratamento de uma doença auto-imune e distúrbio, método de inibição de atividade biológica, método para aumentar uma atividade biológica, método para a detecção de uma doença auto-imune, população de células t cd4+, método para isolar uma população de células t cd4+, kit, uso de um modulador crtam, modulador crtam e anticorpo.
EP2106803A1 (en) 2008-04-04 2009-10-07 Fondazione Centro San Raffaele del Monte Tabor Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
NZ588406A (en) * 2008-04-23 2012-05-25 Healthlinx Ltd An assay comprising determining levels of biomarkers including ca125 and at least one selected from agr-2, midkine and crp for detecting a gynecological condition
CA2731854C (en) * 2008-07-25 2020-06-30 Cellestis Limited Measurement of cell-mediated immune response reactivity to detect or monitor a disease or condition
US9459253B2 (en) * 2009-12-23 2016-10-04 Cellestis Limited Assay for measuring cell-mediated immunoresponsiveness
SI2726883T2 (sl) 2011-06-29 2022-09-30 Cellestis Limited Test celično posredovanega imunskega odziva s povečano občutljivostjo

Also Published As

Publication number Publication date
US20190101536A1 (en) 2019-04-04
RU2018107763A3 (da) 2021-06-01
EP2726883A4 (en) 2015-02-18
TR201808740T4 (tr) 2018-07-23
PT2726883T (pt) 2018-06-05
CY1120633T1 (el) 2019-12-11
AU2012276280A1 (en) 2014-01-09
CA2840484C (en) 2020-04-14
AU2022202799A1 (en) 2022-05-19
BR112013033520B1 (pt) 2021-03-09
EP2726883B2 (en) 2022-05-18
SI2726883T1 (en) 2018-06-29
AU2017213471A1 (en) 2017-08-31
CA2840484A1 (en) 2013-01-03
US9983207B2 (en) 2018-05-29
MX357717B (es) 2018-07-20
WO2013000021A1 (en) 2013-01-03
ES2673697T3 (es) 2018-06-25
EP2726883B1 (en) 2018-03-28
RU2647468C2 (ru) 2018-03-15
KR20140066991A (ko) 2014-06-03
US20140220601A1 (en) 2014-08-07
CN115144594A (zh) 2022-10-04
KR102022513B1 (ko) 2019-09-19
LT2726883T (lt) 2018-06-11
RU2013154967A (ru) 2015-08-10
BR112013033520A2 (pt) 2017-02-07
RU2018107763A (ru) 2019-02-25
HUE037801T2 (hu) 2018-09-28
BR112013033520A8 (pt) 2018-07-17
AU2019222928A1 (en) 2019-09-19
EP2726883A1 (en) 2014-05-07
AU2019222928B2 (en) 2022-02-03
SI2726883T2 (sl) 2022-09-30
ES2673697T5 (es) 2022-09-14
MX2013015259A (es) 2014-04-16
CN103703375B (zh) 2018-04-10
ZA201309155B (en) 2015-03-25
AU2012276280B2 (en) 2017-05-25
JP2014521052A (ja) 2014-08-25
JP6150177B2 (ja) 2017-06-21
DK2726883T3 (da) 2018-07-16
CN108593936B (zh) 2022-05-13
CN108593936A (zh) 2018-09-28
CN103703375A (zh) 2014-04-02
EP3351936A1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
DK2726883T4 (da) Cellemedieret immunresponsanalyse med forbedret følsomhed
FR23C1023I2 (fr) Anticorps anti-il-36r
DK3467500T3 (da) Cobinder-understøttede assayfremgangsmåder
DK4056105T3 (da) Analytsensorindretninger
DK2783216T3 (da) Immunoassays med signalamplifikation
BR112014009251A2 (pt) sensor de tampão
DK3275892T3 (da) Præfusions-rsv-f-antigener
DE102013212915A8 (de) Trägheitssensor
DK2893011T3 (da) Vaske- eller rengøringsmiddel med forbedret enzym-ydeevne
BR112013033747A2 (pt) sensores
FR2975488B1 (fr) Capteur
BR112013029333A2 (pt) detecção de nível
DK3421997T3 (da) Cellemedieret immunresponsanalyse
DE112013004003A5 (de) Sensor mit einfacher Verbindungstechnik
EP2681555A4 (en) PROOF OF AN IMMUNE RESPONSE
DE112012000353A5 (de) Nietverbindung
IT1403662B1 (it) Sistema di raccolta degli sfridi di roccatura
GB201111723D0 (en) Salmonella detection assay
BR112014005253A2 (pt) ensaio de detecção molecular
DK2614333T3 (da) Følerstiftanordning
EE05663B1 (et) Sensormaterjal
DE112011104961A5 (de) Induktiver Sensor
DE112012000176A5 (de) Sensor-Baugruppe
FR2976073B1 (fr) Capteur de contrainte
SG11201504392XA (en) Anti-mif antibody cell migration assay